Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials

María-Victoria Mateos, Suzanne Trudel, Hang Quach, Paweł Robak, Meral Beksac, Ludek Pour, Marek Hus, Kihyun Kim, Vera Zherebtsova, Sosana Delimpasi, Tomas Jelínek, Christopher Ward, P. Joy Ho, Vladimir Vorobyev, Marcelo Pitombeira de Lacerda, Gracia Aparecida-Martinez, Ivan Spicka, Jakub Radocha, Michele Cavo, Claudio Cerchione, Chengcheng Fu, Kazuhito Suzuki, Rachel Rogers, Amy Phillips-Jones, Zhaohui Wang, Hena Baig, Jodie Wilkes, Xiaoou L. Zhou, Eric Lewis, Lydia Eccersley, Neal Sule, Prani Paka, Joanna B. Opalinska, Pralay Mukhopadhyay, Vania Hungria, Meletios Athanasios Dimopoulos

Open source

DOI: 10.1182/bloodadvances.2025016949
Published: 2025-11-12
Container: Blood Advances
Publisher: American Society of Hematology
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025016949,
  title = {Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials},
  author = {María-Victoria Mateos and Suzanne Trudel and Hang Quach and Paweł Robak and Meral Beksac and Ludek Pour and Marek Hus and Kihyun Kim and Vera Zherebtsova and Sosana Delimpasi and Tomas Jelínek and Christopher Ward and P. Joy Ho and Vladimir Vorobyev and Marcelo Pitombeira de Lacerda and Gracia Aparecida-Martinez and Ivan Spicka and Jakub Radocha and Michele Cavo and Claudio Cerchione and Chengcheng Fu and Kazuhito Suzuki and Rachel Rogers and Amy Phillips-Jones and Zhaohui Wang and Hena Baig and Jodie Wilkes and Xiaoou L. Zhou and Eric Lewis and Lydia Eccersley and Neal Sule and Prani Paka and Joanna B. Opalinska and Pralay Mukhopadhyay and Vania Hungria and Meletios Athanasios Dimopoulos},
  year = {2025},
  journal = {Blood Advances},
  doi = {10.1182/bloodadvances.2025016949},
  url = {https://doi.org/10.1182/bloodadvances.2025016949}
}

RIS

TY  - JOUR
TI  - Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials
AU  - María-Victoria Mateos
AU  - Suzanne Trudel
AU  - Hang Quach
AU  - Paweł Robak
AU  - Meral Beksac
AU  - Ludek Pour
AU  - Marek Hus
AU  - Kihyun Kim
AU  - Vera Zherebtsova
AU  - Sosana Delimpasi
AU  - Tomas Jelínek
AU  - Christopher Ward
AU  - P. Joy Ho
AU  - Vladimir Vorobyev
AU  - Marcelo Pitombeira de Lacerda
AU  - Gracia Aparecida-Martinez
AU  - Ivan Spicka
AU  - Jakub Radocha
AU  - Michele Cavo
AU  - Claudio Cerchione
AU  - Chengcheng Fu
AU  - Kazuhito Suzuki
AU  - Rachel Rogers
AU  - Amy Phillips-Jones
AU  - Zhaohui Wang
AU  - Hena Baig
AU  - Jodie Wilkes
AU  - Xiaoou L. Zhou
AU  - Eric Lewis
AU  - Lydia Eccersley
AU  - Neal Sule
AU  - Prani Paka
AU  - Joanna B. Opalinska
AU  - Pralay Mukhopadhyay
AU  - Vania Hungria
AU  - Meletios Athanasios Dimopoulos
PY  - 2025
JO  - Blood Advances
DO  - 10.1182/bloodadvances.2025016949
UR  - https://doi.org/10.1182/bloodadvances.2025016949
ER  -

APA

Mateos, M., Trudel, S., Quach, H., Robak, P., Beksac, M., Pour, L., Hus, M., Kim, K., Zherebtsova, V., Delimpasi, S., Jelínek, T., Ward, C., Ho, P. J., Vorobyev, V., Lacerda, M. P. D., Aparecida-Martinez, G., Spicka, I., Radocha, J., Cavo, M., Cerchione, C., Fu, C., Suzuki, K., Rogers, R., Phillips-Jones, A., Wang, Z., Baig, H., Wilkes, J., Zhou, X. L., Lewis, E., Eccersley, L., Sule, N., Paka, P., Opalinska, J. B., Mukhopadhyay, P., Hungria, V., & Dimopoulos, M. A. (2025). Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials. Blood Advances. https://doi.org/10.1182/bloodadvances.2025016949

Source records

crossref · retrieved 2026-09-27T14:04:04.965Z